Court Finds in Favor of Mylan in Patent Infringement Suit Related to Certain Teva Copaxone® Patents

Mylan Inc. (Nasdaq: MYL ) today announced that Judge Katherine Forrest of the U.S. District Court for the Southern District of New York has dismissed Teva's (NASDAQ: TEVA ) lawsuit alleging that Mylan's Abbreviated New Drug Application ("ANDA") for its generic version of Copaxone® (glatiramer acetate) would infringe